TMC Life Sciences Berhad (KLSE:TMCLIFE)
Malaysia · Delayed Price · Currency is MYR 0.4400
-0.0050 (-1.12%)
At close: Jun 8, 2026
TMC Life Sciences Berhad Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 386.95 | 345.54 | 346.42 | 311.44 | 243.77 | 201.02 |
Other Revenue | 0.1 | 0.1 | - | 0.11 | - | - |
| 387.04 | 345.63 | 346.42 | 311.56 | 243.77 | 201.02 | |
Revenue Growth (YoY) | 18.58% | -0.23% | 11.19% | 27.81% | 21.27% | 9.20% |
Cost of Revenue | 256.68 | 235.97 | 208.4 | 185.5 | 155.89 | 131.52 |
Gross Profit | 130.37 | 109.67 | 138.02 | 126.06 | 87.88 | 69.5 |
Other Operating Expenses | 66.15 | 63.36 | 52.75 | 53 | 39.94 | 30.65 |
Operating Expenses | 103.51 | 97.46 | 80.66 | 79.01 | 55.79 | 43.67 |
Operating Income | 26.85 | 12.21 | 57.36 | 47.05 | 32.09 | 25.84 |
Interest Expense | -8.03 | -9.32 | -10.25 | -9.4 | -2.09 | -0.44 |
Interest & Investment Income | 2.86 | 4.17 | 5.47 | 3.25 | 2 | 2.19 |
EBT Excluding Unusual Items | 21.69 | 7.06 | 52.58 | 40.89 | 32 | 27.58 |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | - | - | - | 0.06 |
Other Unusual Items | 0 | 0 | 0.04 | - | 0.18 | 0.03 |
Pretax Income | 21.71 | 7.07 | 52.62 | 40.89 | 32.18 | 27.67 |
Income Tax Expense | 6.55 | 3.47 | 11.97 | 1.63 | -9.21 | 7.42 |
Net Income | 15.16 | 3.61 | 40.65 | 39.26 | 41.39 | 20.25 |
Net Income to Common | 15.16 | 3.61 | 40.65 | 39.26 | 41.39 | 20.25 |
Net Income Growth | 586.68% | -91.13% | 3.54% | -5.15% | 104.35% | 27.14% |
Shares Outstanding (Basic) | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 |
Shares Outstanding (Diluted) | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 |
EPS (Basic) | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 |
EPS (Diluted) | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 |
EPS Growth | 586.66% | -91.13% | 3.71% | -5.31% | 104.85% | 27.18% |
Free Cash Flow | 39.42 | -18.2 | 49.41 | 22.61 | -32.04 | -80.18 |
Free Cash Flow Per Share | 0.02 | -0.01 | 0.03 | 0.01 | -0.02 | -0.05 |
Dividend Per Share | 0.002 | 0.002 | 0.005 | 0.004 | 0.003 | 0.002 |
Dividend Growth | -61.96% | -61.96% | 16.65% | 51.97% | 24.74% | 9.98% |
Gross Margin | 33.68% | 31.73% | 39.84% | 40.46% | 36.05% | 34.57% |
Operating Margin | 6.94% | 3.53% | 16.56% | 15.10% | 13.16% | 12.85% |
Profit Margin | 3.92% | 1.04% | 11.73% | 12.60% | 16.98% | 10.08% |
Free Cash Flow Margin | 10.18% | -5.27% | 14.26% | 7.26% | -13.15% | -39.89% |
EBITDA | 54.71 | 37.81 | 80.28 | 68.43 | 44.62 | 36.02 |
EBITDA Margin | 14.13% | 10.94% | 23.17% | 21.96% | 18.30% | 17.92% |
D&A For EBITDA | 27.85 | 25.6 | 22.92 | 21.38 | 12.54 | 10.19 |
EBIT | 26.85 | 12.21 | 57.36 | 47.05 | 32.09 | 25.84 |
EBIT Margin | 6.94% | 3.53% | 16.56% | 15.10% | 13.16% | 12.85% |
Effective Tax Rate | 30.18% | 49.01% | 22.75% | 3.99% | - | 26.81% |